These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34228541)

  • 1. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
    Gamal A; Long L; Herrada J; Aram J; McCormick TS; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0054921. PubMed ID: 34228541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
    Pfaller MA; Messer SA; Deshpande LM; Rhomberg PR; Utt EA; Castanheira M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
    Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
    J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal drugs work together to treat germs causing fungal infections.
    Pfaller MA; Messer SA; Deshpande LM; Rhomberg PR; Utt EA; Castanheira M
    Future Microbiol; 2021 Jul; 16():765-768. PubMed ID: 34184545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution.
    Mesquida A; Alcoceba E; Padilla E; Ramírez A; Merino P; González-Romo F; De Carolis E; Sanguinetti M; Mantecón-Vallejo MLÁ; Muñoz-Algarra M; Durán-Valle T; Pérez-Ayala A; Gómez-García-de-la-Pedrosa E; Del Carmen Martínez-Jiménez M; Sánchez-Castellano MÁ; Quiles-Melero I; Cuétara MS; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
    Mycoses; 2024 Mar; 67(3):e13706. PubMed ID: 38438313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.
    Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J
    Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Herrada J; Gamal A; Long L; Sanchez SP; McCormick TS; Ghannoum MA
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33846131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
    Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.
    Dong J; Liang G; Zheng H; Kan S; Song N; Zhang M; Liu W
    Mycoses; 2021 Jun; 64(6):651-655. PubMed ID: 33609301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.